What we’ll cover
- The evolving landscape for AI and health data – what EU and UK developments mean in practice for product strategy, scale and commercial opportunity
- Standards, coding & normalisation – why robust data foundations underpin interoperability, AI performance and long-term value
- AI implementation – what works, what doesn’t, and why, from data readiness to real-world adoption
- How data & AI impact company valuation – how investors and acquirers assess data quality, defensibility, scalability and risk.
Who should attend: Founders and CEOs of European healthcare software companies
We hope you can join us on 26 February at 14:00 UTC/15:00 CET for a practical and candid discussion, with time for live Q&A.
Speakers
Alex Eavis, Chief Product & Technology Officer at Genomics and serial health tech founder
Alex has built and scaled national healthcare data platforms, including EMIS-X analytics infrastructure spanning 35 million longitudinal primary and community care patient records. Her experience architecting large-scale, real-world health datasets gives her a unique perspective on how data architecture, AI strategy, and product decisions translate directly into enterprise value.
Dr Indra Joshi, Chief Development Officer at Optum UK and global leader in digital health and AI
Former founder of the NHS AI Lab, Indra has led the development and deployment of the NHS Federated Data Platform, encompassing 50 million secondary care patient records. She brings deep experience in translating national-scale data infrastructure and AI innovation into measurable healthcare impact across complex enterprise environments.
Host
Sebastien Jacquemoud
Portfolio Director, Healthcare at Upliift, working with founders to ensure AI strategies are implemented effectively to create long-term value. He is co-author of the Founders’ Guide to Implementing an AI Strategy.
We appreciate your confidentiality and the webinar setting will allow you to attend anonymously and submit questions confidentially.
